<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04284579</url>
  </required_header>
  <id_info>
    <org_study_id>IndonesiaUAnes50</org_study_id>
    <nct_id>NCT04284579</nct_id>
  </id_info>
  <brief_title>Optimum Time for Intravenous Cannulation After Induction With Sevoflurane in Pediatric Patient</brief_title>
  <official_title>Determination Effective Dose 95 (ED95) of Intravenous Cannulation With the Induction of Sevoflurane 8 Vol% in Patients Aged 1-3 Years Using Dixon up and Down Method</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indonesia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indonesia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aimed to determinate effective dose 95 (ED95) intravenous cannulation in pediatric
      patient after induction of sevoflurane 8 vol%
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twenty-two subjects were given informed consent before study enrolled. Anesthesia was induced
      by 8% sevoflurane with 6 L flow of 100% oxygen. IV cannulation was attempted at 2 min in the
      first child in each group. The time for cannulation in the next child was stepped up or down
      by 15 s depending on positive or negative response, respectively, in the previous child.
      Children were recruited till a minimum of six pairs of failure-success sequence which was
      obtained in the group. The mean of midpoints of the failure-success sequence was calculated
      to obtain the time for cannulation in 50% of the group.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 27, 2019</start_date>
  <completion_date type="Actual">November 30, 2019</completion_date>
  <primary_completion_date type="Actual">July 5, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ED50 in intravenous cannulation after sevoflurane induction</measure>
    <time_frame>2 minutes</time_frame>
    <description>using Dixon Up and Down Method</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Movement After Intravenous Cannulation</condition>
  <arm_group>
    <arm_group_label>time for cannulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>intravenous cannulation after sevoflurane induction</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IV cannula</intervention_name>
    <description>We measure the time duration needed for IV cannulation</description>
    <arm_group_label>time for cannulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 1-3 year

          -  Physical state ASA I dan II

          -  Parents of patients who agreed to participate and sign informed consent.

        Exclusion criteria:

          -  Patients with difficult airway

          -  There's allergic reaction or drug's side effect after induction

          -  There's cardiorespiratory problem such as anaphylactic shock, aritmia, severe
             hypotension, desaturation before-on-or after induction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>3 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jefferson K Hidayat</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indonesia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Indonesia University</name>
      <address>
        <city>Jakarta</city>
        <state>DKI Jakarta</state>
        <zip>10430</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <results_reference>
    <citation>Schwartz D, Connelly NR, Gutta S, Freeman K, Gibson C. Early intravenous cannulation in children during sevoflurane induction. Paediatr Anaesth. 2004 Oct;14(10):820-4.</citation>
    <PMID>15385009</PMID>
  </results_reference>
  <results_reference>
    <citation>Kumar KR, Sinha R, Chandiran R, Pandey RK, Darlong V, Chandralekha. Evaluation of optimum time for intravenous cannulation after sevoflurane induction of anesthesia in different pediatric age groups. J Anaesthesiol Clin Pharmacol. 2017 Jul-Sep;33(3):371-374. doi: 10.4103/joacp.JOACP_58_16.</citation>
    <PMID>29109638</PMID>
  </results_reference>
  <results_reference>
    <citation>Kilicaslan A, Gök F, Erol A, Okesli S, Sarkilar G, Otelcioglu Ş. Response to Makkar and Singh's comment on our article 'Determination of optimum time for intravenous cannulation after induction with sevoflurane and nitrous oxide in children premedicated with midazolam'. Paediatr Anaesth. 2015 Mar;25(3):328-9. doi: 10.1111/pan.12611.</citation>
    <PMID>25623378</PMID>
  </results_reference>
  <results_reference>
    <citation>Whalen FX, Bacon DR, Smith HM. Inhaled anesthetics: an historical overview. Best Pract Res Clin Anaesthesiol. 2005 Sep;19(3):323-30. Review.</citation>
    <PMID>16013684</PMID>
  </results_reference>
  <results_reference>
    <citation>Behne M, Wilke HJ, Harder S. Clinical pharmacokinetics of sevoflurane. Clin Pharmacokinet. 1999 Jan;36(1):13-26. Review.</citation>
    <PMID>9989340</PMID>
  </results_reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 23, 2020</study_first_submitted>
  <study_first_submitted_qc>February 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 26, 2020</study_first_posted>
  <last_update_submitted>February 23, 2020</last_update_submitted>
  <last_update_submitted_qc>February 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indonesia University</investigator_affiliation>
    <investigator_full_name>Jefferson K Hidayat</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>child, general anesthesia, induction of anesthesia, sevoflurane, venous cannulation</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

